Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Operating Expenses: 2019-2025

Historic Operating Expenses for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to $41.8 million.

  • Benitec Biopharma's Operating Expenses rose 77.25% to $9.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $41.8 million, marking a year-over-year increase of 85.70%. This contributed to the annual value of $41.8 million for FY2025, which is 85.70% up from last year.
  • According to the latest figures from FY2025, Benitec Biopharma's Operating Expenses is $41.8 million, which was up 85.70% from $22.5 million recorded in FY2024.
  • Over the past 5 years, Benitec Biopharma's Operating Expenses peaked at $41.8 million during FY2025, and registered a low of $13.7 million during FY2021.
  • For the 3-year period, Benitec Biopharma's Operating Expenses averaged around $27.8 million, with its median value being $22.5 million (2024).
  • Data for Benitec Biopharma's Operating Expenses shows a peak YoY soared of 85.70% (in 2025) over the last 5 years.
  • Benitec Biopharma's Operating Expenses (Yearly) stood at $13.7 million in 2021, then skyrocketed by 31.29% to $17.9 million in 2022, then rose by 6.86% to $19.2 million in 2023, then rose by 17.40% to $22.5 million in 2024, then skyrocketed by 85.70% to $41.8 million in 2025.